Administrative Core

行政核心

基本信息

项目摘要

This Core will provide the infrastructure necessary for achieving the scientific goals of the projects. The Core will be responsible for program administration, interaction with CCHMC, and coordinating meetings between Project leaders and their respective faculty and staff members. The Administrative Core will play an important role in promoting and maintaining optimal communication between investigators, in fiscal administration, and will play a role in coordinating human subjects recruitment and administrative issues for each of the projects. The Administrative Core will ensure that the scientific efforts are coordinated, and that communication between the investigators is optimized. The Core will coordinate monthly meetings of the Project leaders, their respective postdoctoral and clinical fellows, graduate students and technical staff. The Administrative Core will be responsible for organizing an Annual Retreat to be held off campus for the investigators and their extended staff to meet and assess the progress made within each project and to coordinate future experiments. To gain additional perspective, two external advisors will be invited to attend and participate in this annual meeting. Their feedback will be important in assessing progress as well as planning future directions. The Administrative Core will also be involved in administrating and allocating funds. Under Dr. Gurjit K. Khurana Hershey's supervision, Mr. Granger Butler will handle all financial administration of the program project.
该核心将为实现项目的科学目标提供必要的基础设施。的核心

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gurjit K. Khurana Hershey其他文献

Frequent exacerbator—a novel endotype of pediatric asthma
  • DOI:
    10.1016/j.jaci.2025.05.006
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Kieran J. Phelan;Gurjit K. Khurana Hershey
  • 通讯作者:
    Gurjit K. Khurana Hershey
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop
针对过敏性疾病和哮喘的生物标志物驱动的药物开发:FDA 公共研讨会
  • DOI:
    10.1016/j.jaci.2025.03.014
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Ronald L. Rabin;Matthew C. Altman;S. Hasan Arshad;Richard D. Beger;Pamela A. Frischmeyer-Guerrerio;Elena Goleva;Robert G. Hamilton;Gurjit K. Khurana Hershey;Mohamed H. Shamji;Hugh A. Sampson;Alexandra F. Santos;Wayne G. Shreffler;Alkis Togias;Stefan Vieths;Erik Wambre;Sally E. Wenzel;Kathleen Hise;Joohee Lee;Anubha Tripathi;Jay E. Slater
  • 通讯作者:
    Jay E. Slater
Rhinoconjunctivitis symptoms in children and adolescents with asthma: Longitudinal clustering analysis
哮喘儿童和青少年的鼻结膜炎症状:纵向聚类分析
  • DOI:
    10.1016/j.jaci.2024.12.1084
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Alkis Togias;Peter J. Gergen;Andrew H. Liu;Haejin Kim;Robert A. Wood;George T. O’Connor;Melanie Makhija;Gurjit K. Khurana Hershey;Carolyn M. Kercsmar;Rebecca S. Gruchalla;Carin Lamm;Leonard B. Bacharier;Shilpa J. Patel;James E. Gern;Daniel J. Jackson;Cynthia M. Visness;Agustin Calatroni;William W. Busse
  • 通讯作者:
    William W. Busse
emTSLP/em disease-associated genetic variants combined with airway TSLP expression influence asthma risk
  • DOI:
    10.1016/j.jaci.2021.05.033
  • 发表时间:
    2022-01-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Liza Bronner Murrison;Xiaomeng Ren;Kristina Preusse;Hua He;John Kroner;Xiaoting Chen;Seth Jenkins;Elisabet Johansson;Jocelyn M. Biagini;Matthew T. Weirauch;Raphael Kopan;Lisa J. Martin;Gurjit K. Khurana Hershey
  • 通讯作者:
    Gurjit K. Khurana Hershey
High number of early respiratory infections in association with allergic sensitization to mold promotes childhood asthma
  • DOI:
    10.1016/j.jaci.2017.11.058
  • 发表时间:
    2018-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Leilanie Perez Ramirez;Heepke Wendroth;Lisa J. Martin;Valentina V. Pilipenko;Hua He;John Kroner;Patrick H. Ryan;Grace K. LeMasters;James E. Lockey;David I. Bernstein;Gurjit K. Khurana Hershey;Jocelyn M. Biagini Myers
  • 通讯作者:
    Jocelyn M. Biagini Myers

Gurjit K. Khurana Hershey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gurjit K. Khurana Hershey', 18)}}的其他基金

Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10620999
  • 财政年份:
    2023
  • 资助金额:
    $ 12.99万
  • 项目类别:
Multi-omics of the Frequent Exacerbator Asthmatic
频繁加重哮喘的多组学
  • 批准号:
    10197294
  • 财政年份:
    2021
  • 资助金额:
    $ 12.99万
  • 项目类别:
Multi-omics of the Frequent Exacerbator Asthmatic
频繁加重哮喘的多组学
  • 批准号:
    10596089
  • 财政年份:
    2021
  • 资助金额:
    $ 12.99万
  • 项目类别:
Multi-omics of the Frequent Exacerbator Asthmatic
频繁加重哮喘的多组学
  • 批准号:
    10390405
  • 财政年份:
    2021
  • 资助金额:
    $ 12.99万
  • 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
  • 批准号:
    10379962
  • 财政年份:
    2020
  • 资助金额:
    $ 12.99万
  • 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
  • 批准号:
    10596577
  • 财政年份:
    2020
  • 资助金额:
    $ 12.99万
  • 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
  • 批准号:
    9974832
  • 财政年份:
    2020
  • 资助金额:
    $ 12.99万
  • 项目类别:
Role and Regulation of TSLP in Childhood Allergic Disease
TSLP在儿童过敏性疾病中的作用和调节
  • 批准号:
    10307538
  • 财政年份:
    2017
  • 资助金额:
    $ 12.99万
  • 项目类别:
Role and Regulation of TSLP in Childhood Allergic Disease
TSLP在儿童过敏性疾病中的作用和调节
  • 批准号:
    10063471
  • 财政年份:
    2017
  • 资助金额:
    $ 12.99万
  • 项目类别:
Infrastructure and Opportunity Fund Management
基础设施和机会基金管理
  • 批准号:
    8329216
  • 财政年份:
    2011
  • 资助金额:
    $ 12.99万
  • 项目类别:

相似海外基金

Human secreted IgD: structure, interactions and mechanisms in allergic inflammation and asthma
人类分泌的 IgD:过敏性炎症和哮喘的结构、相互作用和机制
  • 批准号:
    MR/V010557/1
  • 财政年份:
    2021
  • 资助金额:
    $ 12.99万
  • 项目类别:
    Research Grant
Environmental Pollutants Potentiate Allergic Inflammation via Functional Axis of Aryl hydrocarbon Receptor, ROS, and CaMKII in Asthma
环境污染物通过芳基烃受体、ROS 和 CaMKII 功能轴在哮喘中加剧过敏性炎症
  • 批准号:
    10404097
  • 财政年份:
    2019
  • 资助金额:
    $ 12.99万
  • 项目类别:
Environmental Pollutants Potentiate Allergic Inflammation via Functional Axis of Aryl hydrocarbon Receptor, ROS, and CaMKII in Asthma
环境污染物通过芳基烃受体、ROS 和 CaMKII 功能轴在哮喘中加剧过敏性炎症
  • 批准号:
    9817088
  • 财政年份:
    2019
  • 资助金额:
    $ 12.99万
  • 项目类别:
Environmental Pollutants Potentiate Allergic Inflammation via Functional Axis of Aryl hydrocarbon Receptor, ROS, and CaMKII in Asthma
环境污染物通过芳基烃受体、ROS 和 CaMKII 功能轴在哮喘中加剧过敏性炎症
  • 批准号:
    10161717
  • 财政年份:
    2019
  • 资助金额:
    $ 12.99万
  • 项目类别:
Targeting microRNA (miRNA) as a unified therapeutic approach to the treatment of asthma and allergic inflammation
靶向 microRNA (miRNA) 作为治疗哮喘和过敏性炎症的统一治疗方法
  • 批准号:
    nhmrc : 1004267
  • 财政年份:
    2011
  • 资助金额:
    $ 12.99万
  • 项目类别:
    NHMRC Project Grants
SP-A Regulation of Host Response in Asthma and Allergic Inflammation
SP-A 调节哮喘和过敏性炎症中的宿主反应
  • 批准号:
    8325217
  • 财政年份:
    2009
  • 资助金额:
    $ 12.99万
  • 项目类别:
Dehydroxymethylepoxyquinomicin(DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodeling in murine models of asthma
脱羟甲基环氧喹诺星 (DHMEQ) 是一种新型 NF-kappaB 抑制剂,可抑制哮喘小鼠模型中的过敏性炎症和气道重塑
  • 批准号:
    21659206
  • 财政年份:
    2009
  • 资助金额:
    $ 12.99万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Role of IL-3 in allergic inflammation: modulation of basophils, mast cells, eosinophils and remodelling in asthma.
IL-3 在过敏性炎症中的作用:调节嗜碱性粒细胞、肥大细胞、嗜酸性粒细胞和哮喘重塑。
  • 批准号:
    nhmrc : 471481
  • 财政年份:
    2008
  • 资助金额:
    $ 12.99万
  • 项目类别:
    NHMRC Project Grants
IMMUNOGENETIC DISEASES-ALLERGIC INFLAMMATION TO AIRWAY REMODELING IN ASTHMA
免疫性疾病——哮喘中气道重塑的过敏性炎症
  • 批准号:
    7725315
  • 财政年份:
    2008
  • 资助金额:
    $ 12.99万
  • 项目类别:
IMMUNOGENETIC DISEASE-ALLERGIC INFLAMMATION TO AIRWAY REMODELING IN ASTHMA
哮喘气道重塑的免疫性疾病过敏性炎症
  • 批准号:
    7609596
  • 财政年份:
    2007
  • 资助金额:
    $ 12.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了